OpenSAFELY Vaccine Coverage Report

AstraZeneca / Priority Group 1

Data from combined, up to 2021-03-17.

Vaccinated at 2021-03-17 (%) Vaccinated at 2021-03-17 (n) Population Vaccinated at 2021-03-10 (%) Vaccinated in past week (%)
Overall - 66.3% 200,249 301,882 65.6% 0.7%
Sex Female 66.7% 127,813 191,709 66.2% 0.5%
Male 65.7% 72,436 110,173 64.7% 1.0%
Ethnicity White - British 66.9% 128,387 191,968 66.2% 0.7%
White - Irish 67.9% 1,701 2,506 67.6% 0.3%
White - Any other White background 58.0% 3,647 6,293 57.0% 1.0%
Mixed - White and Black Caribbean 59.3% 357 602 57.0% 2.3%
Mixed - White and Black African 50.0% 126 252 47.2% 2.8%
Mixed - White and Asian 60.6% 140 231 60.6% 0.0%
Mixed - Any other mixed background 62.3% 301 483 59.4% 2.9%
Asian or Asian British - Indian 64.1% 1,323 2,065 62.7% 1.4%
Asian or Asian British - Pakistani 55.6% 490 882 53.2% 2.4%
Asian or Asian British - Bangladeshi 60.3% 245 406 56.9% 3.4%
Asian or Asian British - Any other Asian background 57.6% 686 1,190 56.5% 1.2%
Black or Black British - Caribbean 58.1% 1,330 2,289 56.9% 1.2%
Black or Black British - African 50.2% 707 1,407 48.8% 1.5%
Black or Black British - Any other Black background 57.4% 434 756 54.6% 2.8%
Other ethnic groups - Chinese 56.9% 203 357 56.9% 0.0%
Other ethnic groups - Any other ethnic group 59.6% 693 1,162 58.4% 1.2%
Patients with any other ethnicity code 67.9% 26,481 38,983 67.2% 0.7%
Ethnicity not stated 64.7% 1,785 2,758 64.2% 0.5%
Ethnicity not recorded 66.0% 31,108 47,166 65.4% 0.5%
Ethnicity (broad categories) White 66.6% 133,749 200,788 65.9% 0.7%
Mixed 58.8% 938 1,596 56.6% 2.2%
South Asian 60.6% 2,765 4,564 58.9% 1.7%
Black 55.7% 2,485 4,459 54.2% 1.6%
Other 58.4% 896 1,533 57.5% 0.9%
Unknown 66.8% 59,388 88,914 66.2% 0.6%
Index of Multiple Deprivation 1 (most deprived) 64.2% 39,060 60,872 63.3% 0.8%
2 68.5% 43,148 63,035 67.5% 0.9%
3 67.8% 43,050 63,525 67.1% 0.6%
4 66.5% 40,243 60,522 65.9% 0.6%
5 (least deprived) 64.6% 33,607 52,059 64.1% 0.4%
Unknown 60.8% 1,120 1,841 58.9% 1.9%
Clinical Risk Groups Patients in Any Clinical Risk Group 67.4% 175,483 260,421 66.7% 0.7%
Patients with Immunosuppression 65.4% 6,020 9,205 64.8% 0.6%
Patients with CKD 66.3% 49,903 75,250 66.0% 0.3%
Patients who have Chronic Respiratory Disease 65.8% 18,368 27,902 65.4% 0.5%
Patients with Diabetes 66.6% 38,017 57,050 66.1% 0.6%
Patients with Chronic Liver disease 65.4% 5,173 7,910 64.2% 1.2%
Patients with CNS Disease (including Stroke/TIA) 68.5% 104,874 153,076 67.9% 0.6%
Patients with Chronic heart disease 66.5% 72,296 108,647 66.2% 0.4%
Patients with Asplenia or Dysfunction of the Spleen 67.0% 1,547 2,310 66.1% 0.9%
Patients with Wider Learning Disability 74.7% 33,845 45,297 72.9% 1.8%
Patients with Severe Mental Health 66.0% 19,880 30,142 64.7% 1.2%
Other Groups Patients who are shielding (High Risk from COVID-19) 67.7% 143,339 211,806 67.3% 0.4%
Patients with Morbid Obesity 66.7% 5,453 8,176 65.1% 1.6%
Patients who are pregnant 23.8% 35 147 23.8% 0.0%